EliTech to Distribute Curetis Unyvero Products in Belgium, Luxembourg | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular diagnostics company Curetis today announced a deal with EliTech BNL to distribute its products in Belgium and Luxembourg.

Terms of the deal were not disclosed.

EliTech BNL, formerly call Lucron Bioproducts, is part of the EliTech Group and supported Cepheid's entry into the Benelux market, Curetis said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.